Abstract
The use of immunosuppressant drugs and also biological DMARDs in the treatment of juvenile idiopathic arthritis (JIA) may weaken patient's immunity and raise the risk of serious infections, including tuberculosis (TB).
Highlights
The use of immunosuppressant drugs and biological DMARDs in the treatment of juvenile idiopathic arthritis (JIA) may weaken patient’s immunity and raise the risk of serious infections, including tuberculosis (TB).infection in all patients receiving biologics was the mildness of clinical manifestation of the disease.In addition 3 cases of primary TB complex were observed in patients with systemic JIA before initiation of biological DMARD and required prior specific TB therapy
Pediatric Rheumatology European Society (PReS)-FINAL-2019: Tuberculosis infection observed in patients receiving biological DMARDs for treatment of juvenile idiopathic arthritis
Infection in all patients receiving biologics was the mildness of clinical manifestation of the disease
Summary
The use of immunosuppressant drugs and biological DMARDs in the treatment of juvenile idiopathic arthritis (JIA) may weaken patient’s immunity and raise the risk of serious infections, including tuberculosis (TB).infection in all patients receiving biologics was the mildness of clinical manifestation of the disease.In addition 3 cases of primary TB complex were observed in patients with systemic JIA before initiation of biological DMARD and required prior specific TB therapy. PReS-FINAL-2019: Tuberculosis infection observed in patients receiving biological DMARDs for treatment of juvenile idiopathic arthritis From 20th Pediatric Rheumatology European Society (PReS) Congress Ljubljana, Slovenia.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
